Clinical Gastroenterology and Hepatology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=547910, encodeId=886354e910ba, content=投了一篇关于biomarker的.没送审.直接被拒了.样本一百多例.采用的是elisa分析目的分子.结合分析临床指标.分析预后等因素.可能编辑觉得太low了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1010, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/27/dc7b280f49af7fee2e92128f03a39234.jpg, createdBy=d2d11969271, createdName=hongweicheng, createdTime=Wed Oct 04 11:23:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188318, encodeId=6d3b21883183b, content=请问食管方面研究送这家收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe282089782, createdName=kal晨, createdTime=Tue Feb 20 14:24:04 CST 2024, time=2024-02-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=565802, encodeId=3a215658028c, content=哪位大神知道收case report的期刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=914, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99cb2367566, createdName=122e6feam74(暂无昵称), createdTime=Sun Jan 20 20:08:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096682, encodeId=96f4209668217, content=投了一篇case，祝好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Fri Oct 28 14:16:11 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587980, encodeId=558e58e980b6, content=哪里都有你132****5832暂无昵称 2019-10-25 00:00:00 发表: 有没有投稿成功的, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 有没有投稿成功的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e7b1966142, createdName=平常心小刚, createdTime=Thu Apr 02 00:00:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806951, encodeId=4ed68069514c, content=两个月内中了两篇letter，这个杂志letter很准时，都是固定第七天也就是一周时间的时候给回复accept。团队也有其他人投letter，不感兴趣的话拒的倒是很快，一两天就会给拒稿。接收后2周内可以见网，正式出刊时间比较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=455, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Sat Aug 08 17:10:14 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088841, encodeId=37e0108884128, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088842, encodeId=3e7d10888428f, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587979, encodeId=c4b358e97990, content=这个杂志很难的，比APT 还难墨墨235 2020-03-10 00:00:00 发表: 投了一篇meta，三天拒稿，虽说很多人都讲这个杂志IF虚高，但感觉还是很难的。, beContent=墨墨235 2020-03-10 00:00:00 发表: 投了一篇meta，三天拒稿，虽说很多人都讲这个杂志IF虚高，但感觉还是很难的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=449, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e7b1966142, createdName=平常心小刚, createdTime=Thu Apr 02 00:00:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586307, encodeId=e90f58630ee9, content=审稿速度:1.0 经验分享：投了一篇meta，三天拒稿，虽说很多人都讲这个杂志IF虚高，但感觉还是很难的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/5259302daef50326f389537442a87163/990afa84b9e72947320d7dfe819c08d5.jpg, createdBy=48d45231791, createdName=墨墨235, createdTime=Tue Mar 10 00:00:00 CST 2020, time=2020-03-10, status=1, ipAttribution=)]

2017-10-04 hongweicheng

投了一篇关于biomarker的.没送审.直接被拒了.样本一百多例.采用的是elisa分析目的分子.结合分析临床指标.分析预后等因素.可能编辑觉得太low了.

1010 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=547910, encodeId=886354e910ba, content=投了一篇关于biomarker的.没送审.直接被拒了.样本一百多例.采用的是elisa分析目的分子.结合分析临床指标.分析预后等因素.可能编辑觉得太low了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1010, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/27/dc7b280f49af7fee2e92128f03a39234.jpg, createdBy=d2d11969271, createdName=hongweicheng, createdTime=Wed Oct 04 11:23:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188318, encodeId=6d3b21883183b, content=请问食管方面研究送这家收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe282089782, createdName=kal晨, createdTime=Tue Feb 20 14:24:04 CST 2024, time=2024-02-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=565802, encodeId=3a215658028c, content=哪位大神知道收case report的期刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=914, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99cb2367566, createdName=122e6feam74(暂无昵称), createdTime=Sun Jan 20 20:08:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096682, encodeId=96f4209668217, content=投了一篇case，祝好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Fri Oct 28 14:16:11 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587980, encodeId=558e58e980b6, content=哪里都有你132****5832暂无昵称 2019-10-25 00:00:00 发表: 有没有投稿成功的, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 有没有投稿成功的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e7b1966142, createdName=平常心小刚, createdTime=Thu Apr 02 00:00:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806951, encodeId=4ed68069514c, content=两个月内中了两篇letter，这个杂志letter很准时，都是固定第七天也就是一周时间的时候给回复accept。团队也有其他人投letter，不感兴趣的话拒的倒是很快，一两天就会给拒稿。接收后2周内可以见网，正式出刊时间比较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=455, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Sat Aug 08 17:10:14 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088841, encodeId=37e0108884128, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088842, encodeId=3e7d10888428f, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587979, encodeId=c4b358e97990, content=这个杂志很难的，比APT 还难墨墨235 2020-03-10 00:00:00 发表: 投了一篇meta，三天拒稿，虽说很多人都讲这个杂志IF虚高，但感觉还是很难的。, beContent=墨墨235 2020-03-10 00:00:00 发表: 投了一篇meta，三天拒稿，虽说很多人都讲这个杂志IF虚高，但感觉还是很难的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=449, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e7b1966142, createdName=平常心小刚, createdTime=Thu Apr 02 00:00:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586307, encodeId=e90f58630ee9, content=审稿速度:1.0 经验分享：投了一篇meta，三天拒稿，虽说很多人都讲这个杂志IF虚高，但感觉还是很难的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/5259302daef50326f389537442a87163/990afa84b9e72947320d7dfe819c08d5.jpg, createdBy=48d45231791, createdName=墨墨235, createdTime=Tue Mar 10 00:00:00 CST 2020, time=2020-03-10, status=1, ipAttribution=)]

2024-02-20 kal晨来自江苏省

请问食管方面研究送这家收吗

107 0

[GetPortalCommentsPageByObjectIdResponse(id=547910, encodeId=886354e910ba, content=投了一篇关于biomarker的.没送审.直接被拒了.样本一百多例.采用的是elisa分析目的分子.结合分析临床指标.分析预后等因素.可能编辑觉得太low了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1010, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/27/dc7b280f49af7fee2e92128f03a39234.jpg, createdBy=d2d11969271, createdName=hongweicheng, createdTime=Wed Oct 04 11:23:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188318, encodeId=6d3b21883183b, content=请问食管方面研究送这家收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe282089782, createdName=kal晨, createdTime=Tue Feb 20 14:24:04 CST 2024, time=2024-02-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=565802, encodeId=3a215658028c, content=哪位大神知道收case report的期刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=914, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99cb2367566, createdName=122e6feam74(暂无昵称), createdTime=Sun Jan 20 20:08:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096682, encodeId=96f4209668217, content=投了一篇case，祝好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Fri Oct 28 14:16:11 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587980, encodeId=558e58e980b6, content=哪里都有你132****5832暂无昵称 2019-10-25 00:00:00 发表: 有没有投稿成功的, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 有没有投稿成功的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e7b1966142, createdName=平常心小刚, createdTime=Thu Apr 02 00:00:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806951, encodeId=4ed68069514c, content=两个月内中了两篇letter，这个杂志letter很准时，都是固定第七天也就是一周时间的时候给回复accept。团队也有其他人投letter，不感兴趣的话拒的倒是很快，一两天就会给拒稿。接收后2周内可以见网，正式出刊时间比较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=455, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Sat Aug 08 17:10:14 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088841, encodeId=37e0108884128, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088842, encodeId=3e7d10888428f, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587979, encodeId=c4b358e97990, content=这个杂志很难的，比APT 还难墨墨235 2020-03-10 00:00:00 发表: 投了一篇meta，三天拒稿，虽说很多人都讲这个杂志IF虚高，但感觉还是很难的。, beContent=墨墨235 2020-03-10 00:00:00 发表: 投了一篇meta，三天拒稿，虽说很多人都讲这个杂志IF虚高，但感觉还是很难的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=449, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e7b1966142, createdName=平常心小刚, createdTime=Thu Apr 02 00:00:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586307, encodeId=e90f58630ee9, content=审稿速度:1.0 经验分享：投了一篇meta，三天拒稿，虽说很多人都讲这个杂志IF虚高，但感觉还是很难的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/5259302daef50326f389537442a87163/990afa84b9e72947320d7dfe819c08d5.jpg, createdBy=48d45231791, createdName=墨墨235, createdTime=Tue Mar 10 00:00:00 CST 2020, time=2020-03-10, status=1, ipAttribution=)]

2019-01-20 122e6feam74(暂无昵称)

哪位大神知道收case report的期刊吗

914 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=547910, encodeId=886354e910ba, content=投了一篇关于biomarker的.没送审.直接被拒了.样本一百多例.采用的是elisa分析目的分子.结合分析临床指标.分析预后等因素.可能编辑觉得太low了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1010, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/27/dc7b280f49af7fee2e92128f03a39234.jpg, createdBy=d2d11969271, createdName=hongweicheng, createdTime=Wed Oct 04 11:23:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188318, encodeId=6d3b21883183b, content=请问食管方面研究送这家收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe282089782, createdName=kal晨, createdTime=Tue Feb 20 14:24:04 CST 2024, time=2024-02-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=565802, encodeId=3a215658028c, content=哪位大神知道收case report的期刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=914, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99cb2367566, createdName=122e6feam74(暂无昵称), createdTime=Sun Jan 20 20:08:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096682, encodeId=96f4209668217, content=投了一篇case，祝好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Fri Oct 28 14:16:11 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587980, encodeId=558e58e980b6, content=哪里都有你132****5832暂无昵称 2019-10-25 00:00:00 发表: 有没有投稿成功的, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 有没有投稿成功的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e7b1966142, createdName=平常心小刚, createdTime=Thu Apr 02 00:00:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806951, encodeId=4ed68069514c, content=两个月内中了两篇letter，这个杂志letter很准时，都是固定第七天也就是一周时间的时候给回复accept。团队也有其他人投letter，不感兴趣的话拒的倒是很快，一两天就会给拒稿。接收后2周内可以见网，正式出刊时间比较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=455, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Sat Aug 08 17:10:14 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088841, encodeId=37e0108884128, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088842, encodeId=3e7d10888428f, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587979, encodeId=c4b358e97990, content=这个杂志很难的，比APT 还难墨墨235 2020-03-10 00:00:00 发表: 投了一篇meta，三天拒稿，虽说很多人都讲这个杂志IF虚高，但感觉还是很难的。, beContent=墨墨235 2020-03-10 00:00:00 发表: 投了一篇meta，三天拒稿，虽说很多人都讲这个杂志IF虚高，但感觉还是很难的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=449, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e7b1966142, createdName=平常心小刚, createdTime=Thu Apr 02 00:00:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586307, encodeId=e90f58630ee9, content=审稿速度:1.0 经验分享：投了一篇meta，三天拒稿，虽说很多人都讲这个杂志IF虚高，但感觉还是很难的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/5259302daef50326f389537442a87163/990afa84b9e72947320d7dfe819c08d5.jpg, createdBy=48d45231791, createdName=墨墨235, createdTime=Tue Mar 10 00:00:00 CST 2020, time=2020-03-10, status=1, ipAttribution=)]

2022-10-28 隔壁王校长

投了一篇case，祝好运

227 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=547910, encodeId=886354e910ba, content=投了一篇关于biomarker的.没送审.直接被拒了.样本一百多例.采用的是elisa分析目的分子.结合分析临床指标.分析预后等因素.可能编辑觉得太low了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1010, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/27/dc7b280f49af7fee2e92128f03a39234.jpg, createdBy=d2d11969271, createdName=hongweicheng, createdTime=Wed Oct 04 11:23:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188318, encodeId=6d3b21883183b, content=请问食管方面研究送这家收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe282089782, createdName=kal晨, createdTime=Tue Feb 20 14:24:04 CST 2024, time=2024-02-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=565802, encodeId=3a215658028c, content=哪位大神知道收case report的期刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=914, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99cb2367566, createdName=122e6feam74(暂无昵称), createdTime=Sun Jan 20 20:08:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096682, encodeId=96f4209668217, content=投了一篇case，祝好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Fri Oct 28 14:16:11 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587980, encodeId=558e58e980b6, content=哪里都有你132****5832暂无昵称 2019-10-25 00:00:00 发表: 有没有投稿成功的, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 有没有投稿成功的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e7b1966142, createdName=平常心小刚, createdTime=Thu Apr 02 00:00:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806951, encodeId=4ed68069514c, content=两个月内中了两篇letter，这个杂志letter很准时，都是固定第七天也就是一周时间的时候给回复accept。团队也有其他人投letter，不感兴趣的话拒的倒是很快，一两天就会给拒稿。接收后2周内可以见网，正式出刊时间比较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=455, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Sat Aug 08 17:10:14 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088841, encodeId=37e0108884128, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088842, encodeId=3e7d10888428f, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587979, encodeId=c4b358e97990, content=这个杂志很难的，比APT 还难墨墨235 2020-03-10 00:00:00 发表: 投了一篇meta，三天拒稿，虽说很多人都讲这个杂志IF虚高，但感觉还是很难的。, beContent=墨墨235 2020-03-10 00:00:00 发表: 投了一篇meta，三天拒稿，虽说很多人都讲这个杂志IF虚高，但感觉还是很难的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=449, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e7b1966142, createdName=平常心小刚, createdTime=Thu Apr 02 00:00:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586307, encodeId=e90f58630ee9, content=审稿速度:1.0 经验分享：投了一篇meta，三天拒稿，虽说很多人都讲这个杂志IF虚高，但感觉还是很难的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/5259302daef50326f389537442a87163/990afa84b9e72947320d7dfe819c08d5.jpg, createdBy=48d45231791, createdName=墨墨235, createdTime=Tue Mar 10 00:00:00 CST 2020, time=2020-03-10, status=1, ipAttribution=)]

2020-04-02 平常心小刚

哪里都有你132****5832暂无昵称 2019-10-25 00:00:00 发表:
有没有投稿成功的

132****5832暂无昵称 2019-10-25 00:00:00 发表: 有没有投稿成功的

437 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=547910, encodeId=886354e910ba, content=投了一篇关于biomarker的.没送审.直接被拒了.样本一百多例.采用的是elisa分析目的分子.结合分析临床指标.分析预后等因素.可能编辑觉得太low了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1010, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/27/dc7b280f49af7fee2e92128f03a39234.jpg, createdBy=d2d11969271, createdName=hongweicheng, createdTime=Wed Oct 04 11:23:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188318, encodeId=6d3b21883183b, content=请问食管方面研究送这家收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe282089782, createdName=kal晨, createdTime=Tue Feb 20 14:24:04 CST 2024, time=2024-02-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=565802, encodeId=3a215658028c, content=哪位大神知道收case report的期刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=914, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99cb2367566, createdName=122e6feam74(暂无昵称), createdTime=Sun Jan 20 20:08:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096682, encodeId=96f4209668217, content=投了一篇case，祝好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Fri Oct 28 14:16:11 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587980, encodeId=558e58e980b6, content=哪里都有你132****5832暂无昵称 2019-10-25 00:00:00 发表: 有没有投稿成功的, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 有没有投稿成功的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e7b1966142, createdName=平常心小刚, createdTime=Thu Apr 02 00:00:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806951, encodeId=4ed68069514c, content=两个月内中了两篇letter，这个杂志letter很准时，都是固定第七天也就是一周时间的时候给回复accept。团队也有其他人投letter，不感兴趣的话拒的倒是很快，一两天就会给拒稿。接收后2周内可以见网，正式出刊时间比较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=455, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Sat Aug 08 17:10:14 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088841, encodeId=37e0108884128, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088842, encodeId=3e7d10888428f, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587979, encodeId=c4b358e97990, content=这个杂志很难的，比APT 还难墨墨235 2020-03-10 00:00:00 发表: 投了一篇meta，三天拒稿，虽说很多人都讲这个杂志IF虚高，但感觉还是很难的。, beContent=墨墨235 2020-03-10 00:00:00 发表: 投了一篇meta，三天拒稿，虽说很多人都讲这个杂志IF虚高，但感觉还是很难的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=449, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e7b1966142, createdName=平常心小刚, createdTime=Thu Apr 02 00:00:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586307, encodeId=e90f58630ee9, content=审稿速度:1.0 经验分享：投了一篇meta，三天拒稿，虽说很多人都讲这个杂志IF虚高，但感觉还是很难的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/5259302daef50326f389537442a87163/990afa84b9e72947320d7dfe819c08d5.jpg, createdBy=48d45231791, createdName=墨墨235, createdTime=Tue Mar 10 00:00:00 CST 2020, time=2020-03-10, status=1, ipAttribution=)]

2020-08-08 1484bf18m20暂无昵称

两个月内中了两篇letter，这个杂志letter很准时，都是固定第七天也就是一周时间的时候给回复accept。团队也有其他人投letter，不感兴趣的话拒的倒是很快，一两天就会给拒稿。接收后2周内可以见网，正式出刊时间比较长

455 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=547910, encodeId=886354e910ba, content=投了一篇关于biomarker的.没送审.直接被拒了.样本一百多例.采用的是elisa分析目的分子.结合分析临床指标.分析预后等因素.可能编辑觉得太low了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1010, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/27/dc7b280f49af7fee2e92128f03a39234.jpg, createdBy=d2d11969271, createdName=hongweicheng, createdTime=Wed Oct 04 11:23:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188318, encodeId=6d3b21883183b, content=请问食管方面研究送这家收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe282089782, createdName=kal晨, createdTime=Tue Feb 20 14:24:04 CST 2024, time=2024-02-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=565802, encodeId=3a215658028c, content=哪位大神知道收case report的期刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=914, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99cb2367566, createdName=122e6feam74(暂无昵称), createdTime=Sun Jan 20 20:08:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096682, encodeId=96f4209668217, content=投了一篇case，祝好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Fri Oct 28 14:16:11 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587980, encodeId=558e58e980b6, content=哪里都有你132****5832暂无昵称 2019-10-25 00:00:00 发表: 有没有投稿成功的, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 有没有投稿成功的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e7b1966142, createdName=平常心小刚, createdTime=Thu Apr 02 00:00:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806951, encodeId=4ed68069514c, content=两个月内中了两篇letter，这个杂志letter很准时，都是固定第七天也就是一周时间的时候给回复accept。团队也有其他人投letter，不感兴趣的话拒的倒是很快，一两天就会给拒稿。接收后2周内可以见网，正式出刊时间比较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=455, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Sat Aug 08 17:10:14 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088841, encodeId=37e0108884128, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088842, encodeId=3e7d10888428f, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587979, encodeId=c4b358e97990, content=这个杂志很难的，比APT 还难墨墨235 2020-03-10 00:00:00 发表: 投了一篇meta，三天拒稿，虽说很多人都讲这个杂志IF虚高，但感觉还是很难的。, beContent=墨墨235 2020-03-10 00:00:00 发表: 投了一篇meta，三天拒稿，虽说很多人都讲这个杂志IF虚高，但感觉还是很难的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=449, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e7b1966142, createdName=平常心小刚, createdTime=Thu Apr 02 00:00:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586307, encodeId=e90f58630ee9, content=审稿速度:1.0 经验分享：投了一篇meta，三天拒稿，虽说很多人都讲这个杂志IF虚高，但感觉还是很难的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/5259302daef50326f389537442a87163/990afa84b9e72947320d7dfe819c08d5.jpg, createdBy=48d45231791, createdName=墨墨235, createdTime=Tue Mar 10 00:00:00 CST 2020, time=2020-03-10, status=1, ipAttribution=)]

2021-12-29 乌云背后的幸福线

期刊给我发了一封信，但我看不懂怎么办？

320 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=547910, encodeId=886354e910ba, content=投了一篇关于biomarker的.没送审.直接被拒了.样本一百多例.采用的是elisa分析目的分子.结合分析临床指标.分析预后等因素.可能编辑觉得太low了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1010, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/27/dc7b280f49af7fee2e92128f03a39234.jpg, createdBy=d2d11969271, createdName=hongweicheng, createdTime=Wed Oct 04 11:23:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188318, encodeId=6d3b21883183b, content=请问食管方面研究送这家收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe282089782, createdName=kal晨, createdTime=Tue Feb 20 14:24:04 CST 2024, time=2024-02-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=565802, encodeId=3a215658028c, content=哪位大神知道收case report的期刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=914, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99cb2367566, createdName=122e6feam74(暂无昵称), createdTime=Sun Jan 20 20:08:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096682, encodeId=96f4209668217, content=投了一篇case，祝好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Fri Oct 28 14:16:11 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587980, encodeId=558e58e980b6, content=哪里都有你132****5832暂无昵称 2019-10-25 00:00:00 发表: 有没有投稿成功的, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 有没有投稿成功的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e7b1966142, createdName=平常心小刚, createdTime=Thu Apr 02 00:00:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806951, encodeId=4ed68069514c, content=两个月内中了两篇letter，这个杂志letter很准时，都是固定第七天也就是一周时间的时候给回复accept。团队也有其他人投letter，不感兴趣的话拒的倒是很快，一两天就会给拒稿。接收后2周内可以见网，正式出刊时间比较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=455, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Sat Aug 08 17:10:14 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088841, encodeId=37e0108884128, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088842, encodeId=3e7d10888428f, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587979, encodeId=c4b358e97990, content=这个杂志很难的，比APT 还难墨墨235 2020-03-10 00:00:00 发表: 投了一篇meta，三天拒稿，虽说很多人都讲这个杂志IF虚高，但感觉还是很难的。, beContent=墨墨235 2020-03-10 00:00:00 发表: 投了一篇meta，三天拒稿，虽说很多人都讲这个杂志IF虚高，但感觉还是很难的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=449, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e7b1966142, createdName=平常心小刚, createdTime=Thu Apr 02 00:00:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586307, encodeId=e90f58630ee9, content=审稿速度:1.0 经验分享：投了一篇meta，三天拒稿，虽说很多人都讲这个杂志IF虚高，但感觉还是很难的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/5259302daef50326f389537442a87163/990afa84b9e72947320d7dfe819c08d5.jpg, createdBy=48d45231791, createdName=墨墨235, createdTime=Tue Mar 10 00:00:00 CST 2020, time=2020-03-10, status=1, ipAttribution=)]

2021-12-28 rayms

期刊发送邮件中包括哪几个方面的内容？

320 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=547910, encodeId=886354e910ba, content=投了一篇关于biomarker的.没送审.直接被拒了.样本一百多例.采用的是elisa分析目的分子.结合分析临床指标.分析预后等因素.可能编辑觉得太low了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1010, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/27/dc7b280f49af7fee2e92128f03a39234.jpg, createdBy=d2d11969271, createdName=hongweicheng, createdTime=Wed Oct 04 11:23:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188318, encodeId=6d3b21883183b, content=请问食管方面研究送这家收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe282089782, createdName=kal晨, createdTime=Tue Feb 20 14:24:04 CST 2024, time=2024-02-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=565802, encodeId=3a215658028c, content=哪位大神知道收case report的期刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=914, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99cb2367566, createdName=122e6feam74(暂无昵称), createdTime=Sun Jan 20 20:08:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096682, encodeId=96f4209668217, content=投了一篇case，祝好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Fri Oct 28 14:16:11 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587980, encodeId=558e58e980b6, content=哪里都有你132****5832暂无昵称 2019-10-25 00:00:00 发表: 有没有投稿成功的, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 有没有投稿成功的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e7b1966142, createdName=平常心小刚, createdTime=Thu Apr 02 00:00:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806951, encodeId=4ed68069514c, content=两个月内中了两篇letter，这个杂志letter很准时，都是固定第七天也就是一周时间的时候给回复accept。团队也有其他人投letter，不感兴趣的话拒的倒是很快，一两天就会给拒稿。接收后2周内可以见网，正式出刊时间比较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=455, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Sat Aug 08 17:10:14 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088841, encodeId=37e0108884128, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088842, encodeId=3e7d10888428f, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587979, encodeId=c4b358e97990, content=这个杂志很难的，比APT 还难墨墨235 2020-03-10 00:00:00 发表: 投了一篇meta，三天拒稿，虽说很多人都讲这个杂志IF虚高，但感觉还是很难的。, beContent=墨墨235 2020-03-10 00:00:00 发表: 投了一篇meta，三天拒稿，虽说很多人都讲这个杂志IF虚高，但感觉还是很难的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=449, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e7b1966142, createdName=平常心小刚, createdTime=Thu Apr 02 00:00:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586307, encodeId=e90f58630ee9, content=审稿速度:1.0 经验分享：投了一篇meta，三天拒稿，虽说很多人都讲这个杂志IF虚高，但感觉还是很难的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/5259302daef50326f389537442a87163/990afa84b9e72947320d7dfe819c08d5.jpg, createdBy=48d45231791, createdName=墨墨235, createdTime=Tue Mar 10 00:00:00 CST 2020, time=2020-03-10, status=1, ipAttribution=)]

2020-04-02 平常心小刚

这个杂志很难的，比APT 还难墨墨235 2020-03-10 00:00:00 发表:
投了一篇meta，三天拒稿，虽说很多人都讲这个杂志IF虚高，但感觉还是很难的。

墨墨235 2020-03-10 00:00:00 发表: 投了一篇meta，三天拒稿，虽说很多人都讲这个杂志IF虚高，但感觉还是很难的。

449 0

[GetPortalCommentsPageByObjectIdResponse(id=547910, encodeId=886354e910ba, content=投了一篇关于biomarker的.没送审.直接被拒了.样本一百多例.采用的是elisa分析目的分子.结合分析临床指标.分析预后等因素.可能编辑觉得太low了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1010, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/27/dc7b280f49af7fee2e92128f03a39234.jpg, createdBy=d2d11969271, createdName=hongweicheng, createdTime=Wed Oct 04 11:23:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188318, encodeId=6d3b21883183b, content=请问食管方面研究送这家收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe282089782, createdName=kal晨, createdTime=Tue Feb 20 14:24:04 CST 2024, time=2024-02-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=565802, encodeId=3a215658028c, content=哪位大神知道收case report的期刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=914, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99cb2367566, createdName=122e6feam74(暂无昵称), createdTime=Sun Jan 20 20:08:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096682, encodeId=96f4209668217, content=投了一篇case，祝好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁王校长, createdTime=Fri Oct 28 14:16:11 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587980, encodeId=558e58e980b6, content=哪里都有你132****5832暂无昵称 2019-10-25 00:00:00 发表: 有没有投稿成功的, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 有没有投稿成功的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e7b1966142, createdName=平常心小刚, createdTime=Thu Apr 02 00:00:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806951, encodeId=4ed68069514c, content=两个月内中了两篇letter，这个杂志letter很准时，都是固定第七天也就是一周时间的时候给回复accept。团队也有其他人投letter，不感兴趣的话拒的倒是很快，一两天就会给拒稿。接收后2周内可以见网，正式出刊时间比较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=455, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Sat Aug 08 17:10:14 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088841, encodeId=37e0108884128, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088842, encodeId=3e7d10888428f, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587979, encodeId=c4b358e97990, content=这个杂志很难的，比APT 还难墨墨235 2020-03-10 00:00:00 发表: 投了一篇meta，三天拒稿，虽说很多人都讲这个杂志IF虚高，但感觉还是很难的。, beContent=墨墨235 2020-03-10 00:00:00 发表: 投了一篇meta，三天拒稿，虽说很多人都讲这个杂志IF虚高，但感觉还是很难的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=449, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e7b1966142, createdName=平常心小刚, createdTime=Thu Apr 02 00:00:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586307, encodeId=e90f58630ee9, content=审稿速度:1.0 经验分享：投了一篇meta，三天拒稿，虽说很多人都讲这个杂志IF虚高，但感觉还是很难的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/5259302daef50326f389537442a87163/990afa84b9e72947320d7dfe819c08d5.jpg, createdBy=48d45231791, createdName=墨墨235, createdTime=Tue Mar 10 00:00:00 CST 2020, time=2020-03-10, status=1, ipAttribution=)]

2020-03-10 墨墨235

审稿速度:1.0
经验分享：投了一篇meta，三天拒稿，虽说很多人都讲这个杂志IF虚高，但感觉还是很难的。

469 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务